The company also offers global tape solutions with surgical precision
Wearables continue to be a hot market for Avery Dennison Medical, whose pressure-sensitive adhesive (PSA) materials have played a key role in enabling such applications for more than 20 years. Medica 2023 attendees will have the chance to see the company’s range of products for multiple wearable device applications, including diabetes management, remote vital signs sensing, multi-day drug delivery and other Internet of Things (IoT) digital healthcare solutions.
“We have a broad portfolio of skin contact, tie-layer device and cover tapes, including ready-to-use materials for both short-term and extended-wear devices,” said Miguel Solivan, Marketing Manager for Avery Dennison Medical. The company plans to exhibit its extensive portfolio of products, created specifically to meet the needs of a wide array of wearable device applications." Its material science team will be available to discuss material selection, specification, complex construction techniques and human factors for such devices at Hall 6, Booth H07, at the trade show Nov. 13-16 in Düsseldorf, Germany.
Avery Dennison Medical will also use the show to highlight its adhesive-based surgical solutions for medical device OEMs. Its portfolio of products in this area includes incise films, construction tapes, and drape tapes for bordering or fenestration. All of these adhesives undergo meticulous biocompatibility testing in strict accordance with ISO 10993, guaranteeing their safety for medical applications.
With patient safety at the forefront, “We understand that surgical tape must excel in secure adhesion, reducing the risk of infections while maintaining biocompatibility,” said Product Manager Rachel Jacobs. “This ensures it aligns with the specific requirements of sedated patients and the practical needs of surgeons and nurses.”
The company notes that all of its surgical tape products are sterilizable by gamma and ethylene oxide (ETO) processes, adding to the versatility of its offerings. Additionally, it manufactures all such products in ISO 13485-certified manufacturing facilities in the European Union and North America. Those same facilities are also fully compliant with Good Manufacturing Practices (GMP), underscoring its commitment to excellence in medical device manufacturing.
“We look forward to sharing our advanced products and deep expertise with visitors to our booth at Medica,” said General Manager John Gaffney, “and to helping the OEMs there to streamline their path from development to commercialization.”
www.averydennison.com
